In Vitro Fertilization Market Size By Product (Reagents and Equipments), Type (Insemination, Intracytoplasmic Sperm Injection, Intrauterine, IVF Using Donor Eggs), Cycle (Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, Fresh Donor IVF Cycles, Fresh Non-donor IVF Cycles), End-User (Fertility Clinics, Hospitals, Clinical Research Institutes), and Region - Market Share, Trend Analysis, Competitive Intelligence, Historical Data, and Forecast 2023-2032

Market Perspective

The global In Vitro Fertilization Market size was worth around USD 19.62 billion in 2022 and is predicted to grow around USD 33.93 billion by 2032, with a compound annual growth rate of roughly 6.2% between 2023 and 2032.

IVF is an important infertility treatment and is widely used as assisted reproductive technology treatment. Over the past few decades, the advances in IVF have made this method of impregnation very popular with patients and doctors, and in terms of availability and cost, it has become easier even in low- and middle-income countries. Technological advances in IVF have exceeded imagination with the cryopreservation of surplus embryos.

It is estimated that more than 8 million children are born worldwide after infertility in vitro fertilization (IVF) since the birth of the first IVF in the world 40 years ago. Enormous advances have been made in the treatment of infertility using techniques and methods originally developed from animal and later human research. Some of the technological advances in reproductive medicine have also influenced the development and treatment options in other medical fields.

The use of IVF is closely related to its affordability and availability as more countries are adopting various policies aimed at reversing the decline in birth rates. The perception that fertility is a basic human right is only beginning to spread and has certainly accelerated the wider adoption of such policies. Another recent development is that an increasing number of larger companies are choosing to fund maternity benefits as part of their social mission and to attract and retain employees. The availability of various insurance policies that promote better coverage and lower the cost of IVF treatment for patients is increasing its use.

Key Insights

• Based on product, the reagent segment held the largest market share in 2022
• Based on type, the intrauterine segment dominated the market in 2022
• Based on the cycle, the fresh non-donor IVF cycles segment is expected to register the most significant share over the estimated timeframe
• Based on end-user, the fertility clinics segment is expected to dominate over the forecast period
• based on region, North America accounted largest market share in 2022

Availability of Advanced and Personalized Fertility Treatment to Augment Market Growth

Personalized fertility treatment involves creating customized plans and this individualized care may be influenced by diagnostics, genetic testing, patient preferences, witnessed treatment effects, or particular symptoms. The availability of personalized fertility treatment is the next breakthrough area that continues in genomics which also impacts fertility treatments, enabling truly personalized medicine, screening for reproductive risk factors, and better selection of healthy embryos. The forefront of development is the growing awareness of infertility and awareness of fertility preservation strategies such as oocyte and embryo verification.

The integration of AI aims to create a complete operating system for the next generation of IVF treatment. Fertility technology and clinic collaboration is also an opportunity to improve the reproductive health of patients and the landscape.

In January 2021, Royal Philips entered into a partnership agreement with Merck to develop clinical digital solutions for highly personalized fertility care. The partnership is based on expertise in maternal and fetal monitoring, pregnancy, and baby applications, with the ultrasound solutions and HealthSuite's cloud or AI platform. The fertility technology brand has partnered with fertility clinics in the United States, Canada, and Australia to make fertility treatments more accessible. reducing patient visits and minimizing testing costs with advanced and innovative IVF treatment options.

Increasing Medical Tourism in Emerging Nations Provides Lucrative Opportunity for the Market

The medical tourism sector has grown significantly as a result of top-notch facilities, cutting-edge hospitals, a sizable group of highly qualified medical professionals, and reasonably priced medical care. Many nations have identified medical tourism has significantly boosted the growth of IVF due to the rising demand for medical treatment on a global scale.

For instance, nations such as Thailand, Singapore, India, and Turkey have implemented particular policies to promote and support the flow of patients from other countries. The market is becoming more competitive as contemporary medical technology is being used more widely, which promotes product differentiation between nations.

The success rate and patient experience of fertility therapy have improved significantly in recent years to several developments and trends. Particularly in vitro fertilization (IVF) has seen significant advancements recently, improving patient results and increasing the range of available treatments.

High Costs Associated with IVF Procedures Restrict the Market Growth

Over the past decade, the IVF pregnancy rates have improved through special laboratory techniques which are available to improve the chances of success. Nevertheless, fertility treatments are expensive and frequently only partially supported by insurance. Diagnostic services are not frequently covered by private insurance plans but are costlier treatment services. Most individuals who use reproductive services are required to pay out of pocket, and the costs frequently exceed thousands of dollars. There are only a few countries that have private insurance plans to cover infertility services, and the limited availability of well-defined healthcare programs for low-income people restricts the market growth. Moreover, the in vitro fertilization cycle costs between USD 10,000 and USD 15,000, depending on the complexity of the procedure and the age of the woman. Also, these medications that are used throughout the procedure raise the price of the treatment which restricts the market growth.

Recent Development

In October 2022: TMRW Life Sciences, Inc. launched the most advanced cryopreservation facility for fertility samples which focuses on providing unprecedented transparency into the safety of frozen eggs and embryos at the heart of nearly every IVF process. TMRW uses state-of-the-art digital identification and tracking to inspect samples in and out of storage and creates a complete and secure sample record and audit trail.

In January 2021: Royal Philips partnered with Merck to develop clinical digital solutions for highly personalized fertility care. The solutions using digital health technologies, advanced informatics, and AI mobile ultrasound diagnostics aim to better inform patients and doctors about the selection and timing of fertility treatments to maximize the chances of conception.

Segmentation Analysis

Based on type, the market is segmented into insemination, intracytoplasmic sperm injection, intrauterine, and IVF using donor eggs. Delayed marriages are becoming more common, and more people choose artificial insemination, the intrauterine insemination in vitro fertilization segment held onto the largest share.

Based on the cycle, the market is categorized into frozen non-donor IVF cycles, frozen donor IVF cycles, Fresh Donor IVF Cycles, and fresh non-donor IVF cycles. The fresh non-donor IVF cycles segment dominated the market, which is attributable to various factors such as high success rate, higher birth rates compared to frozen embryos, easy implantation, and fresh embryo transfer results in better results.

The market is categorized based on end users, including clinical research institutes, fertility clinics, and hospitals. Among these, the fertility segment is projected to have the highest market share, as the number of in vitro fertilization (IVF) procedures increases in fertility clinics with the help of specialized staff who provide optimal patient care. Additionally, the growth of the fertility clinics segment is driven by the rise in the number of fertility clinics, growing awareness of their benefits, and declining fertility rates worldwide.

North America to Dominating Market Backed by Governmental Support 

The North America market is the dominating market owing to the prevalence of co-diseases such as polycystic ovary syndrome (PCOS) and government support for sperm and egg storage is contributing to market expansion. In the U.S., IVF success rates for women under 35 rose slightly overall in 2020, with 47.2% of cycles ending in one child, compared to women over 40 who used their eggs and embryos, where 7.2% of cycles resulted in live births. In addition, recently opened fertility centers and fertility compensation practices are driving the demand for infertility treatments, among others.

The presence of established market participants, new products, and increasing product knowledge contribute to market expansion. For instance, in April 2023, CCRM Fertility is seeking participants for a new in vitro maturation (IVM) trial to stimulate the ovaries, so it is more affordable than IVF and has fewer side effects. Eligible study participants receive a free IVM treatment session at CCRM Fertility, which includes a new patient consultation, fertility testing, pre-implantation genetic aneuploidy (PGT-A), anesthesia, and some medication.

IVF treatment in the U.S. is paving the way to provide alternative and less invasive options for people, especially PCOS patients, who want to create, grow or complete their family. The IVF market has been bolstered by rising infertility rates among couples, increased knowledge of IVF, improvements in IVF technology, and an increase in delayed pregnancies.

Asia Pacific is Expected to Growth at the Fastest Rate Owing to the Significant Increase in Medical Tourism

The Asia Pacific region is experiencing the fastest growth in the fertility market, driven by several factors. Medical tourism is rising, with more people traveling to the region for fertility treatments. Additionally, there is growing awareness of the availability of in vitro fertilization methods, which has led to increased demand for in vitro fertilization. The demand for IVF treatment in the Asia Pacific region is expected to increase due to fertility tourism, increased foreign funding to enter economically developing nations, and a changing regulatory environment.

In addition, infertility has increased in frequency as a result of lifestyle changes like an increase in stress and obesity, a decrease in physical activity, poor eating practices, inadequate nutrition, and increased pollution, as well as the prevalence of medical conditions like diabetes, which propels the market growth.

Competitive Landscape

• Cook Group Incorporated
• CooperSurgical, Inc.
• Corning Incorporated
• Ferring B.V.
• FUJIFILM Corporation
• Koninklijke Philips N.V.
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Vitrolife AB
• ZEISS Group

The global in vitro fertilization market is segmented as:

By Product

• Reagents
• Equipments

By Type

• Insemination
• Intracytoplasmic Sperm Injection
• Intrauterine
• IVF Using Donor Eggs
• Others

By Cycle

• Frozen Non-donor IVF Cycles
• Frozen Donor IVF Cycles
• Fresh Donor IVF Cycles
• Fresh Non-donor IVF Cycles

By End User

• Fertility Clinics
• Hospitals
• Clinical Research Institutes

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Reunion
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America